Stock A326030 SK BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SK Biopharmaceuticals Co., Ltd.

Equities

A326030

KR7326030004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
80,700 KRW +1.00% Intraday chart for SK Biopharmaceuticals Co., Ltd. +2.28% -19.62%
May. 10 SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% MT
Jan. 30 SK Biopharmaceuticals Swings to Profit in Q4 MT

Evolution of the average Target Price on SK Biopharmaceuticals Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

04e4a2cfb258bdf1017cd19.tt-wZEDaZarBOh9uX4GPxkUtzAm2h27rksoDunkJ5hE.z5uCOwHuK5OTb1IHMNnfinNom1rd_xTSyPNU-TQ9q3iD7_YwD6AS5KtYSg~ddaf6bcb3c7028797506caa2eab541a9

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
80,700 KRW
Average target price
107,438 KRW
Spread / Average Target
+33.13%
High Price Target
130,000 KRW
Spread / Highest target
+61.09%
Low Price Target
54,000 KRW
Spread / Lowest Target
-33.09%

Consensus detail

Consensus revision (last 18 months)

Ratings for SK Biopharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A326030 Stock
  4. Consensus SK Biopharmaceuticals Co., Ltd.